American Portfolios Advisors Immatics N.V. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Immatics N.V. stock. As of the latest transaction made, American Portfolios Advisors holds 500 shares of IMTX stock, worth $2,770. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$2,770% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$81.3 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$52 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$50.6 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$47.6 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$40.3 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $422M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...